18a生物科技Chapter 18A Guidance Letterchapter 18a listing rules中文gl107-20HKEX Guidance Letterhkex-gl107-20ONC Lawyers
文章推薦指數： 80 %
The Stock Exchange updated Guidance Letter HKEX-GL92-18 (“GL92-18”) to ... be allowed to list under Chapter 18A of the Listing Rules if it can demonstrate, ... Knowledge Knowledge filter Category All Arbitration AssetManagement&Funds Banking&Fina
延伸文章資訊
- 1檔案資料- 指引信 - HKEX Group
30/04/2018 (29/04/2020), 生物科技公司是否適合上市(GL92-18) (於2020年4月刊登的標註修訂版本), 指引信, 上市申請人. 26/03/2013 (28/02...
- 2New HKEx Guidance for Biotech Companies issued in April ...
Guidance Letter HKEx-GL92-18 sets out the criteria for a Biotech company to be considered suitabl...
- 3至合律师
值得注意的是，HKEX-GL92-18 3.3对小分子药品制药、生物制剂、医疗器材（含诊断器材）及联交所认为符合其他生物科技产品定义的其他产品是否超过产品概念 ...
- 4ONC Lawyers
The Stock Exchange updated Guidance Letter HKEX-GL92-18 (“GL92-18”) to ... be allowed to list und...
- 5Bio-tech Listings on HKEX (18A) - 方氏律師事務所
In addition to the main rules stipulated in Chapter 18A, Guidance Letters and a ... HKEX-GL92-18 ...
